Asan Medical Center /ID# 155053

Seoul 05505

0 studies enrolling now · 1 studies all time

What they study most

Crohn Disease

Studies at this site

• A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease — Completed